Charles Brandes acquired 1.13 Million MerckInc shares worth $147 Million. That's 2.09% of their equity portfolio (8th largest holding). The first MerckInc trade was made in Q1 2013. Since then Charles Brandes bought shares thirteen more times and sold shares on 30 occasions. The stake costed the investor $62.4 Million, netting the investor a gain of 136% so far.